
AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …

Regeneron Pharmaceuticals has announced that initial clinical data published in the New England Journal of Medicine shows that its antibody …

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …

Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …

A US-based biotechnology company has been fined $3.5 million by the US Department of Agriculture (USDA) for a case related …

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …

Bristol-Myers Squibb has given signed a 10-year contract with South Korea’s Samsung BioLogics for the manufacture of one of its …
Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …
Astellas has broken ground on a $95 million R&D and manufacturing facility in Santa Monica, USA, that will also serve …